U.S. Energy Services Stock News

Taysha Gene Therapies (NasdaqGS:TSHA) received FDA Breakthrough Therapy designation for TSHA-102 in Rett syndrome. The company reported a 100% patient response rate in pivotal Phase I/II data for TSHA-102. Regulators aligned with Taysha on pivotal trial designs for its lead Rett syndrome program. Taysha added a key commercial hire as it prepares for potential TSHA-102 commercialization. Taysha Gene Therapies, trading at $4.4 per share, has been drawing attention as its 1 year return stands...

Ambarella (NasdaqGS:AMBA) used a recent industry conference to outline a faster push into Edge AI products. The company highlighted a major shift in its revenue mix, new sales efforts aimed at smaller customers, and progress on a semi custom chip. Management also disclosed work on an upcoming two nanometer chip, signaling a move to more advanced manufacturing nodes. Ambarella, trading at about $54.02, has seen a mixed share price record, with a 3.3% gain over the past week but a 28.1%...

Yiren Digital (YRD) is back in focus after Q4 2025 results showed revenue of CN¥957.63 million, a net loss of CN¥882.16 million, and a temporary suspension of its cash dividend for the second half of 2025. See our latest analysis for Yiren Digital. The earnings miss and dividend suspension appear to have weighed heavily on sentiment, with a 7 day share price return of 44.19% and a 1 year total shareholder return of 69.72%. The 3 year total shareholder return remains slightly positive, which...

HeartFlow (NasdaqGS:HTFL) reported landmark real world data at ACC 2026 showing its AI Plaque Analysis as a leading independent predictor for cardiovascular risk stratification. The Plaque Analysis data is linked with improved patient outcomes and substantial cost savings in coronary artery disease management. The company launched the large scale NAVIGATE PCI Registry to study its AI driven PCI Navigator tool ahead of commercial release. HeartFlow’s AI platform is now backed by FDA cleared...

FedEx Q3 2026 Earnings Snapshot FedEx (FDX) has put up another solid set of quarterly numbers, with Q3 2026 revenue at US$24.0 billion and basic EPS of US$4.47, giving investors a clear look at how the business is performing through the current fiscal year. The company has seen revenue move from US$21.2 billion in Q3 2025 to US$24.0 billion in Q3 2026, while quarterly basic EPS shifted from US$3.78 to US$4.47 over the same period. The trailing twelve month net profit margin now sits at 4.9%...

Hexcel is collaborating through the ECCA initiative with James Cropper to develop aerospace grade composites using recycled carbon fibre, supporting circularity and lower waste in advanced materials. The company is also a key materials supplier for Dassault Aviation's Falcon 10X program, which has reached an important aircraft rollout milestone. These developments highlight Hexcel's role in both sustainable material solutions and next generation business jets across the aerospace...

JinkoSolar Holding (NYSE:JKS) has entered a multi year supply agreement with Nextpower for U.S. manufactured steel module frames. The partnership centers on steel frames and deeper localization of JinkoSolar's U.S. solar module supply chain. The agreement supports JinkoSolar's efforts to source key components domestically and align with U.S. solar infrastructure priorities. For investors tracking NYSE:JKS, this move comes with the stock at around $23.4 and a mixed performance profile...

ArcBest's board is urging shareholders to vote against a climate related proposal ahead of the upcoming annual meeting. The proposal calls for the company to set greenhouse gas emission reduction targets. The board's stance highlights tension between management and some shareholders over environmental priorities and disclosure. ArcBest (NasdaqGS:ARCB) enters this vote with a current share price of $87.58 and a mixed recent return profile. The stock is up 3.2% over the past week and 13.5%...

United States Antimony (UAMY) has just reported its FY 2025 numbers, with Q4 revenue of about US$13.0 million and a basic EPS loss of roughly US$0.002. Trailing 12 month figures show revenue at around US$39.3 million and a basic EPS loss of about US$0.035. Over the past six reported quarters, revenue has moved from roughly US$2.6 million in Q3 2024 to US$13.0 million in Q4 2025, with quarterly EPS ranging between a profit of about US$0.0048 and a loss of roughly US$0.039. This sets up a...

Firefly Aerospace (FLY) just closed FY 2025 with fourth quarter revenue of US$57.7 million and a basic EPS loss of US$0.26, alongside trailing twelve month revenue of US$159.9 million and a TTM EPS loss of US$4.83, versus very large revenue growth of 163% over the past year. Over recent quarters, the company has seen revenue move from US$9.0 million in Q4 2024 to US$57.7 million in Q4 2025 while quarterly basic EPS losses shifted from US$7.86 to US$0.26. This leaves investors weighing robust...

Janus Living stock: why this senior housing REIT is on investor radars Janus Living (JAN) has attracted fresh attention after a recent 1 day return of 0.18% and a last close of $23.60, prompting investors to reassess this senior housing focused U.S. REIT. See our latest analysis for Janus Living. The recent 1 day share price return of 18% and year to date share price return of 18% at a current level of $23.60 suggest momentum has been building in a short period. This may hint at shifting...

If you are wondering whether CleanSpark's current share price lines up with its underlying worth, this breakdown will help you connect the stock chart to valuation numbers. CleanSpark closed at US$9.40, with returns of 1.4% over the last 30 days, an 18.6% decline year to date, gains of 26.3% over 1 year, and a very large 3 year return of 249.4%, set against a 55.3% decline over 5 years. Recent coverage has focused on CleanSpark as part of broader commentary on software and tech related...

Darden Restaurants (DRI) just turned in its Q3 2026 scorecard, reporting revenue of US$3.3b and basic EPS of US$2.70. This helps investors weigh the latest quarter against its recent track record. Over the past few periods, revenue has moved from US$3.2b in Q3 2025 to US$3.3b in Q3 2026, while basic EPS went from US$2.76 to US$2.70, giving a clear sense of where the top and bottom lines currently sit. With net profit margin now at 8.7% versus 9.0% a year earlier, the story for this quarter...

If you are wondering whether Andersen Group at US$27.90 is offering fair value or an opportunity, the next sections will walk through what the current price really reflects. The stock has posted returns of 22.2% over the last 7 days, 24.6% over the last 30 days and 14.4% year to date, which has likely caught the eye of investors watching for changing risk and return profiles. Recent coverage has focused on Andersen Group's share price moves and how investors are reassessing the company, with...

EHang’s earnings jump puts quarterly profit in focus EHang Holdings (NasdaqGM:EH) just released its fourth quarter and full year 2025 results, reporting quarterly sales of CN¥243.78 million and net income of CN¥10.49 million. This follows a net loss in the prior year period. See our latest analysis for EHang Holdings. The earnings surprise has arrived against a weak recent share price backdrop, with a 1 day share price return of 8.46% decline, a 30 day share price return of 19.04% decline,...

BrightSpring Health Services (NasdaqGS:BTSG) is reallocating capital toward acquisitions and organic growth in its core home and clinical services. The company is accelerating de-leveraging efforts to increase financial flexibility. BrightSpring plans to divest its community-living operations, with the transaction expected to close soon. BrightSpring operates in home and clinical care, an area that sits at the intersection of aging demographics, pressure on institutional care settings, and...

If you are wondering whether CBIZ's share price now reflects its true worth, the starting point is understanding how that price lines up against different measures of value. The stock recently closed at US$27.02, with returns of 3.4% over the last week, a 9.5% decline over the past month, and longer term returns of a 46.8% decline year to date and a 63.0% decline over the past year. These moves sit against a backdrop where investors have been reassessing many professional services names,...

XPeng (NYSE:XPEV) closed FY 2025 with fourth quarter revenue of C¥22.3b and basic EPS of C¥0.40, while trailing twelve month figures show total revenue of C¥76.7b and a basic EPS loss of C¥1.20, keeping the story firmly focused on scale over the bottom line. The company’s quarterly revenue moved from C¥10.1b in Q3 2024 to C¥22.3b in Q4 2025, with basic EPS shifting from a C¥1.91 loss to C¥0.40, so the latest results sit against a backdrop of expanding sales and still thin margins that...

Boone Capital Management has disclosed a significant new position in Tyra Biosciences. The investment comes as Tyra Biosciences advances multiple clinical trials centered on FGFR3 biology. The move highlights fresh institutional interest in NasdaqGS:TYRA at a current share price of $37.15. For readers tracking Tyra Biosciences, the company now sits at a share price of $37.15 with substantial recent share price momentum, including a 26.4% return over the past 30 days and 38.7% year to date...

Planet Labs PBC (PL) has just closed out FY 2026 with fourth quarter revenue of US$86.8 million and a basic EPS loss of US$0.48. Trailing twelve month revenue stood at US$307.7 million and EPS at a loss of US$0.80. Over recent periods, the company has seen quarterly revenue move from US$61.6 million in FY 2025 Q4 to US$66.3 million in FY 2026 Q1, US$73.4 million in Q2, US$81.3 million in Q3 and US$86.8 million in Q4. This has come alongside a sequence of widening quarterly EPS losses from...

Intellicheck (IDN) has rounded out FY 2025 with fourth quarter revenue of about US$6.6 million and basic EPS of roughly US$0.08, alongside trailing twelve month revenue of US$22.7 million and EPS of about US$0.07 that reflect a move into positive net income of around US$1.3 million over the year. The company has seen quarterly revenue progress from US$4.9 million in Q1 2025 to US$6.6 million in Q4 2025, with EPS shifting from a small loss of roughly US$0.02 per share early in the year to a...

Linde plans to build a new industrial gases facility in Oshkosh, Wisconsin. The project is intended to expand supply capacity for industrial customers across the Midwest. The development marks a further investment in regional infrastructure for NasdaqGS:LIN. Linde, trading on NasdaqGS:LIN, is moving ahead with construction of a new industrial gases facility in Oshkosh, Wisconsin, adding to its US footprint. The company’s shares most recently closed at $488.15, with a return of 13.8% year to...

If you are wondering whether GPGI is attractively priced or already reflecting a lot of optimism, the current share price at US$17.06 raises some useful questions about what you are really paying for. Recent returns are mixed, with the stock up 3.3% over the last week but showing a 27.4% decline over 30 days, an 8.6% decline year to date, and gains of 51.0% over 1 year, 191.8% over 3 years, and 114.8% over 5 years. These moves sit against a backdrop of ongoing coverage that keeps GPGI on...

FDA grants premarket approval to LivaNova's aura6000 System for adult patients with moderate to severe Obstructive Sleep Apnea who do not benefit from standard therapies. The system uses proximal hypoglossal nerve stimulation and is supported by clinical trial data showing meaningful outcomes, including in harder to treat patient groups. LivaNova (NasdaqGS:LIVN) also discloses work on a next generation, MRI compatible version of the aura6000 with additional features. LivaNova, listed on...